CEO contract update
Filed with ASX · · 1 page · English
Summary by 6ix AI
Australian Clinical Labs Ltd has announced that Group CEO and Executive Director Melinda McGrath will not renew her contract upon its conclusion. Melinda has played a crucial role in the company's growth over the past decade, including its IPO on the ASX. The Board expressed gratitude for her leadership and contributions to the company. An extensive recruitment process for a new CEO is currently underway, with further updates to be provided.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/ceo-contract-update
Australian Clinical Labs Ltd on 6ix
In the deck
Earlier from Australian Clinical Labs
- Appendix 4D and 1H26 financial reports
- ACL 1H26 financial results investor presentation
- On Market Share Buy Back
- AIC proceedings - update
- Appendix 4E and Financial Report 30 June 2025
Later from Australian Clinical Labs
- Class action proceedings
- Appointment of new Group CEO
- Appendix 4E and FY26 financial reports
- FY26 financial results investor presentation
Follow Australian Clinical Labs into a list and get an email when it puts out news.
Follow Australian Clinical Labs